Gene: HAND2
Official Full Name: heart and neural crest derivatives expressed 2provided by HGNC
Gene Summary: The protein encoded by this gene belongs to the basic helix-loop-helix family of transcription factors. This gene product is one of two closely related family members, the HAND proteins, which are asymmetrically expressed in the developing ventricular chambers and play an essential role in cardiac morphogenesis. Working in a complementary fashion, they function in the formation of the right ventricle and aortic arch arteries, implicating them as mediators of congenital heart disease. In addition, this transcription factor plays an important role in limb and branchial arch development. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33222 | HAND2 Knockout cell line (HEK293) | Human | HAND2 | 1:3~1:6 | Negative | Online Inquiry |
HAND2 Gene Knockout Cell Lines are specifically engineered cell models designed to study the role and function of the HAND2 (Heart and Neural Crest Derivatives Expressed 2) gene in various biological processes. These cell lines offer a powerful tool for researchers investigating cardiac development, neurogenesis, and associated pathologies, such as congenital heart defects and neurodevelopmental disorders. By providing a loss-of-function model, these cell lines enable a clearer understanding of the downstream effects that result from HAND2 gene disruption.
The key mechanism by which HAND2 Gene Knockout Cell Lines operate lies in the targeted disruption of the HAND2 gene, achieved through advanced CRISPR-Cas9 technology. This innovative approach allows for precise editing of the genomic sequence, leading to a complete knockout of the gene. Researchers can then examine variations in cell behavior, gene expression profiles, and phenotypic changes, illuminating the specific pathways influenced by HAND2 in both normal and pathological states.
The scientific importance of these cell lines extends into both basic research and potential clinical applications. They serve as models for exploring gene-environment interactions and the mechanistic pathways of diseases linked to HAND2 deficiencies. By elucidating these pathways, scientists can aid in the development of therapeutic strategies and personalized medicine approaches, particularly in pediatrics where HAND2 is critical for early development.
A distinct advantage of the HAND2 Gene Knockout Cell Lines is their ease of use combined with reproducibility, allowing for consistent experimental outcomes compared to traditional knockout models. Moreover, these cell lines are readily transfected and can be adapted to a variety of assays, including high-throughput screening. This versatility is critical for both exploratory and confirmatory studies.
Researchers and clinicians will find significant value in these optimized cell lines as they streamline the experimental process, reduce time to results, and ultimately enhance the quality of research outputs. By leveraging the insights gained from these models, users can contribute meaningfully to advancements in genetic research and therapeutic development.
Our company specializes in providing high-quality biological products through established practices and innovative technologies, ensuring that our clients have access to the best tools available for their research and clinical endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.